BioReference Laboratories Inc. (BRLI) Key Ratios

Profile for BioReference Laboratories Inc.  (BRLI) 
$ 18.93   -0.48 (-2.47%) Volume: 374.69 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 18.93 0.00 (0.00%) Volume: 600  4:37 PM EST Feb 10, 2012
Income Statements
Revenue (LTM) ($): 558.64 m
Revenue per Share (LTM) ($): 19.99
Revenue per Employee (LTM) ($): 229,139.45
Revenue Growth 3 Yr: 23.22%
Revenue Growth 5 Yr: 23.22%
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 2.10
Current Ratio: 2.50
Long Term Debt to Total Capital: 0.05
Total Debt to Equity: 0.18
Interest Coverage: 38.10
Leverage Ratio: 1.50
 
Profitability (LTM)
Gross Margin: 50.40%
EBIT Margin: 11.90%
EBITDA Margin: 13.40%
Pre-Tax Profit Margin: 10.40%
Profit Margin (Cont. Op): 6.50%
Profit Margin (Total Op): 6.50%
Management Effectiveness LTM 5 Yr Avg
Return on Equity 19.20% 17.50%
Return on Capital 16.30% 16.30%
Return on Assets 10.90% 10.90%
 
Assets
Asset Turnover: 2.10
Inventory Turnover: 34.90
Receivable Turnover: 4.00
Valuation Measures
P/E Ratio: 14.70
P/E High - Last 5 Years: 35.40
P/E Avg. High - Last 5 Years: 27.40
P/E Low - Last 5 Years: 11.80
P/E Avg. Low - Last 5 Years: 16.20
 
Price to Sales: 0.97
Price to Book: 2.79
Price to Tangible Book: 3.32
Price to Cash Flow: 10.30
Price to Free Cash: 34.30